Revolution Medicines. has been granted a patent for mTOR inhibitors, focusing on compounds and compositions that inhibit mTOR. The patent includes methods for treating various cancers, such as lung and ovarian cancer, through the administration of these therapeutic agents. GlobalData’s report on Revolution Medicines gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Revolution Medicines, Cancer treatment biomarkers was a key innovation area identified from patents. Revolution Medicines's grant share as of July 2024 was 13%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12048749B2 outlines a method for treating various types of cancer, including head and neck cancers, lung cancer, liver cancer, ovarian cancer, prostate cancer, pancreatic cancers, endometrial cancer, vulva cancer, intestinal or rectal cancer, bile duct cancer, and thyroid cancer. The method involves administering a therapeutically effective amount of a specific compound or composition to a subject diagnosed with one of these cancers. The claims detail that the treatment can utilize a compound characterized by a particular chemical formula, although the specific structures of these compounds are not disclosed in the provided text.
Additionally, the patent claims include provisions for various formulations of the compounds, indicating that the treatment may involve different mixtures or compositions. This flexibility in the formulation allows for potential customization based on the specific cancer type or patient needs. The claims emphasize the therapeutic effectiveness of the compounds or compositions in treating the specified cancers, suggesting a targeted approach to cancer therapy. Overall, the patent presents a method that could contribute to the development of new treatment options for patients suffering from these malignancies.
To know more about GlobalData’s detailed insights on Revolution Medicines, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
